Companies Directory

O Instituto Oncoguia, uma associação sem fins lucrativos tem como missão ajudar o paciente com câncer a viver melhor por meio de informação de qualidade e do empoderamento da população e dos pacientes para o autocuidado em saúde, qualidade de vida e cidadania ativa e responsável.

A Oncologia D’Or foi criada em 2010, como um projeto pioneiro da Rede D’Or São Luiz para estabelecer um novo patamar de excelência em diagnóstico e tratamento do câncer no país. Nossa história tem início com a abertura do centro integrado de oncologia no Hospital Quinta D’Or, no Rio de Janeiro. Hoje, somos uma rede com mais 40 unidades de tratamento de quimioterapia e/ou radioterapia, composta por mais de 360 médicos, principalmente oncologistas clínicos e hematologistas, nos estados do Rio de Janeiro, São Paulo, Bahia, Maranhão, Pernambuco, Ceará, Sergipe, Tocantins e no Distrito Federal. Estamos em plena expansão, crescendo de forma integrada à Rede D’Or São Luiz, que hoje conta com mais de 50 hospitais em todo o Brasil. Uma sinergia única que nos garante acesso às mais modernas tecnologias do mundo e aos avanços científicos em todas as áreas da oncologia. Por meio de uma estrutura de alcance nacional, levamos novas perspectivas de prevenção, diagnóstico, tratamento e apoio à recuperação dos pacientes com câncer. Nossa nova identidade visual reflete a essência da nossa marca. Compartilhamos as melhores práticas de forma contínua e em direção ao futuro. Mais do que tecnológica, atualizada. Mais do que abrangente, ilimitada. Oncologia D’Or, uma rede sempre em movimento.

Oncology Information Group provides services included, but not limited to: production of video/audio recordings of interviews with key opinion leaders in a variety of formats, from single speaker, to debates, to panel discussions; event production (complete service from venue negotiation to speaker management, including marketing); e-Learning module development; Preceptorship programs; grant and proposal writing; accreditation application packages; and much more! Offering services in English, Spanish, Portuguese and Romanian.

Oncology International - is a brand of Oncology & Hematology Clinics based out of Bangalore with the aim to provide Comprehensive and Compassionate Care to Cancer Patients, by focusing on early detection and targeted treatment. Oncology International was founded by Dr. Sarode K. Pundaleeka, who is a renowned Oncologist based in Illinois, USA with over 40 years of experience in the field of cancer research and treatment. He is affiliated with Morris Hospital & Healthcare, Presence Mercy Medical Center and Presence Saint Joseph Hospital and is also a philanthropist who believes in giving back to the community.

Oncology Network Australia the online destination for oncology professionals in Australia and beyond. The Oncology Network provides unique digital resources for the oncology professional. Our services include oncologynews.com.au, a tailored, independent news service, oncologyjobs.com.au and The Oncology Newsletter, freely distributed to over 8,000 oncology professionals. A digital networking, publishing and education portal and unique crowdfunding platform are coming soon. Oncologynews.com.au - news from Australia and beyond direct to your desktop, tablet and phone Oncology News gives readers respite from journals with independent aggregated news and exclusive commentary from a broad range of sources. Specifically designed to keep busy oncology professionals informed on the go, content is clear, convenient and compelling. Oncologyjobs.com.au - the only specialist jobs website connected directly to the professional Australian oncology community. Find and advertise new roles - visit oncologynetwork.com.au to find out more. The Oncology Newsletter - distributed fortnightly to Australia's oncology professionals Sign up for The Oncology Newsletter and join over 8000 other oncology professionals receiving our unique content, updates on crowdfunding projects, job postings and much morevisit oncologynews.com.au. The Cancer Crowd - coming soon Launching Soon! We are in the final stages of development of a groundbreaking crowdfunding platform, for cancer research, technology and patient support projects. Its an important part of our mission to give oncology professionals the tools they need to excel. The Hive - coming soon An online media and networking platform offering digital publishing, specialist blogging and educational resources to the international oncology community.

Oncology San Antonio is committed to a comprehensive and compassionate team approach in the diagnosis, treatment and ongoing follow-up care of every cancer patient. We serve San Antonio and South Texas utilizing the latest technologies in radiation oncology and the most advanced chemotherapy treatment protocols.

Oncology Supply, a part of Cencora (formerly AmerisourceBergen), has distributed chemotherapy and supportive care products for nearly 40 years to independent oncology practices through our uniquely integrated specialty distribution network. Our passion is customer satisfaction. Our priority is exceeding expectations by delivering friendly, responsive service, while making the purchasing process easy and reliable to help our practices gain access to life-saving therapies that positively impact cancer patients’ lives. Creating relationships of trust and loyalty is the foundation of our culture. Our experience and stability in the marketplace allows us to understand our customer challenges and achieve timely resolution with transparency. We guarantee the integrity of the origin of all pharmaceutical products we sell by offering best-in-class service and drug management. On August 30, 2023, Oncology Supply became a subsidiary of Cencora when AmerisourceBergen changed its name to Cencora. There are no operational changes at this time. While many parts of our company are still doing business under different names, our purpose is shared. We are united in our responsibility to create healthier futures.

OSL are suppliers of outstanding products, services, support and value to the radiotherapy community. We distribute leading-edge medical technology from state-of-the-art medical imaging, treatment planning and AI-based auto contouring software, external beam and brachytherapy treatment systems, medical physics devices, to radiotherapy patient positioning systems and accessories. OSL can also assist with shielding and SkyCeiling lighting solutions for the exterior and interior of healthcare buildings.

Oncology Imaging Systems Ltd is a forward thinking medical device company dedicated to providing the best products and the best customer service to the radiotherapy and medical physics communities. OIS specialises in patient positioning and immobilisation devices and has recently expanded their range of radiation calibration and QA equipment for dosimetry, brachytherapy, intensity-modulated and image-guided radiotherapy, and stereotactic radiosurgery.

Oncolys BioPharma Inc. is a Tokyo-based bioventure established in Japan in March 2004. Its mission is to contribute to the advancement of medical science in the world through bringing innovation to the existing treatments for cancer and serious infectious diseases, using its virology-based new drug discovery technologies. The company operates in two business segments. Pharmaceutical Business segment is engaged in the research, development, manufacture and marketing of novel drugs. Its major pipeline Telomelysin (OBP-301), an oncolytic adenovirus immunotherapy is in clinical development targeting various types of solid tumors including melanoma , HCC and esophageal cancer. Along with Telomelysin, an anti-HIV drug OBP-601 (Censavudine) and a novel HDAC inhibitor OBP-801 are also under development in the United States. Diagnostics Business segment is engaged in the research, development, manufacture and marketing of CTC (Circulating Tumor Cell) detection adenovirus TelomeScan, as well as the provision of inspection services. Oncolys was listed on the Tokyo Stock Exchange Mothers Market in December 2014 and has a clinical laboratory center in Kobe, Japan and a subsidiary in New Jersey, USA.